v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 29, 2025
Cash flows from operating activities of continuing operations:    
Net income $ 91,539 $ 217,582
Adjustments to reconcile net income to net cash provided by operating activities:    
(Income) loss from discontinued operations (54,615) (97,074)
Depreciation expense 35,620 24,840
Intangible asset amortization expense 67,943 50,668
Deferred financing costs and debt discount amortization expense 2,976 1,705
Loss on extinguishment of debt 1,150 0
Changes in contingent consideration (2,699) 14,080
Stock-based compensation 12,182 12,287
Asset impairment charge 0 8,117
Gain on non-designated foreign currency forward contracts 0 (83,532)
Deferred income taxes, net (16,090) (1,935)
Interest benefit on swaps designated as net investment hedges (15,422) (7,484)
Other 3,140 (6,388)
Changes in assets and liabilities, net of effects of acquisitions and disposals:    
Accounts receivable (23,639) (26,559)
Inventories 44,252 (13,949)
Prepaid expenses and other assets 12,888 (3,734)
Accounts payable, accrued expenses and other liabilities (6,053) (27,643)
Income taxes receivable and payable, net (14,613) (70,277)
Net cash provided by (used in) operating activities from continuing operations 138,559 (9,296)
Cash flows from investing activities of continuing operations:    
Expenditures for property, plant and equipment (32,825) (51,921)
Payments for businesses and intangibles acquired, net of cash acquired 0 (6,700)
Insurance settlement proceeds 0 9,447
Net payments on swaps designated as net investment hedges (39,542) 7,612
Purchase of investments (9,000) (5,000)
Net cash used in investing activities from continuing operations (81,367) (46,562)
Cash flows from financing activities of continuing operations:    
Proceeds from new borrowings 2,350,000 300,000
Reduction in borrowings (2,175,000) (55,375)
Repurchase of common stock (250,000) (300,000)
Net (payments) proceeds from share based compensation plans and related tax impacts (5,265) 7,207
Share repurchase excise tax (2,802) (1,894)
Payments for contingent consideration (107) (112)
Dividends paid (29,830) (30,218)
Debt issuance and amendment fees (13,981) (2,800)
Net cash used in financing activities from continuing operations (126,985) (83,192)
Cash flows from discontinued operations:    
Net cash provided by operating activities 4,796 90,131
Net cash used in investing activities (18,144) (12,718)
Net cash (used in) provided by discontinued operations (13,348) 77,413
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents (6,420) 17,908
Net decrease in cash, cash equivalents and restricted cash equivalents (89,561) (43,729)
Cash, cash equivalents and restricted cash equivalents at the beginning of the period 453,848 327,650
Less: Cash, cash equivalents and restricted cash of discontinued operations (47,368) (27,365)
Cash, cash equivalents and restricted cash equivalents at the end of the period $ 316,919 $ 256,556